We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Amgen ...

Four companies from an industry with little to no Columbus-area presence in 2020 now have a combined 1,200 high-paying jobs.

Every week, reporter Jim Weiker rounds up the biggest business news of the week in his Breaking Ground newsletter. Check out his latest.

Analysts highlight MariTide's upcoming updates and near-term catalysts, while Amgen's price targets shift amid steady outlook ...

The firm is expecting Phase III readouts this year for its FGFR2b drug bemarituzumab and is advancing a second KRAS inhibitor to the clinic.

Q1 2025 Earnings Call Transcript May 1, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $4.9, expectations were $4.27. Operator: My name is Julianne and I’ll be your conference ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

James Bradner; Executive Vice President, Research and Development, and Chief Scientific Officer; Amgen Inc Peter Griffith; Executive Vice President and Chief Financial Officer; Amgen Inc Good ...

Amgen (NASDAQ:AMGN) reported a 24% rise in first-quarter profit, fueled by strong product sales, while reaffirming full-year ...